News
Mount Sinai Researchers Publish Landmark Cell Review Defining the “Hallmarks of Liver Cancer”
Overview
“This work brings together decades of research to better understand what drives liver cancer and how we can treat it more effectively. By applying the Hallmarks of Cancer framework, we connect the biology of these tumors with real therapeutic opportunities, helping guide more precise and personalized care.”
-Josep M. Llovet, MD, PhD, Professor of Medicine at the Icahn School of Medicine (Liver Diseases) at Mount Sinai
The Big Picture
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
